Results 41 to 50 of about 49,783 (286)
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T. +9 more
core +2 more sources
association oF systemic Diseases witH retinal vein occlusive Disease
Retinal vein occlusion (RVO) is the second commonest vascular disease of the eye, second only to Diabetic Retinopathy. The association of the retinal vein occlusion with other systemic disease likes hypertension, diabetes mellitus and others has been ...
Rajesh Kishor Shrestha +3 more
doaj +1 more source
Assessment of Ischemic Index in Retinal Vascular Diseases Using Ultra-Wide-Field Fluorescein Angiography:Single Versus Summarized Image [PDF]
Background and Objective: To compare a single image with a computer-generated summarized image from the ultra-wide-field fluorescein angiogram (UWFFA) sequence for evaluation of ischemic index (ISI).Materials and Methods: UWFFA sequences from patients ...
Apap, David +7 more
core +2 more sources
An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy [PDF]
AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: Thirty-two DME patients were enrolled.
Carnovale, Anna +7 more
core +1 more source
Retinal vascular occlusion is the most common cause of retinopathy leading to severe visual loss in all age groups. Central retinal vein occlusion (CRVO) is usually seen in older age group and is often associated with systemic vascular diseases. Although
Rohina S Aggarwal +2 more
doaj +1 more source
BILATERAL SIMULTANEOUS CENTRAL RETINAL VEIN OCCLUSION IN A PATIENT WITH SYSTEMIC HYPERTENSION
The central retinal vein occlusion is caused by age related changes in the retinal vessels. Bilateral central retinal vein occlusion is a relatively rare event. Only less than 10% cases are bilateral.
Basim Mubarik, Aamir Ali Choudhry
doaj
Retinal vein occlusions are the second most common form of retinal vascular disease. Previously, laser treatment for branch retinal vein occlusion and intravitreal triamcinolone acetonide for central retinal vein occlusion were the standard of care ...
Daniel D. Esmaili, David S. Boyer
doaj +1 more source
Background The ophthalmic manifestation of neurosarcoidosis is varied. The complication of optic neuropathy and central retinal vein occlusion (CRVO) is rare in sarcoidosis.
Miki Hiraoka
doaj +1 more source
Retinal vascular occlusion in patients with the Covid-19 virus
Background The coronavirus disease (COVID-19) can cause acute respiratory distress syndrome with dyspnea, anosmia, fever, and cough. Few studies describing ocular findings have been reported.
Helio F. Shiroma +7 more
doaj +1 more source
Central retinal vein occlusion caused by anomalous prepapillary venous loop
We present a case of prepapillary venous loop complicated by central retinal vein occlusion (CRVO). A 56-year-old female reported to us with blurring of vision in the right eye, noticed 8 days ago.
Pradeep Gajanan Tekade +2 more
doaj +1 more source

